Efficacy and safety of DA-6034(AJU-S56/GLH8NDE) in patients with dry eye disease: A multicenter, randomized, double-blinded, placebo-controlled phase 2 study

被引:0
|
作者
Kim, Eunjung [1 ]
Park, Jun [1 ]
Chung, Tae [2 ]
机构
[1] GL PharmTech, R&D, Seongnam, Gyeonggi Do, South Korea
[2] Samsung Med Ctr, Ophthalmol, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
3980
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Safety and Efficacy of Esreboxetine in Patients With Fibromyalgia: An 8-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
    Arnold, Lesley M.
    Chatamra, Krai
    Hirsch, Ian
    Stoker, Malcolm
    CLINICAL THERAPEUTICS, 2010, 32 (09) : 1618 - 1632
  • [42] Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson's disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study
    Hattori, N.
    Takeda, A.
    Takeda, S.
    Nishimura, A.
    Kitagawa, T.
    Mochizuki, H.
    Nagai, M.
    Takahashi, R.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 231 - 232
  • [43] Efficacy and tolerability of oral stevioside in patients with type 2 diabetes: a long-term, randomized, double-blinded, placebo-controlled study
    Jeppesen, P. B.
    Barriocanal, L.
    Meyer, M. T.
    Palacios, M.
    Canete, F.
    Benitez, S.
    Logwin, S.
    Schupmann, Y.
    Benitez, G.
    Jimenez, J. T.
    DIABETOLOGIA, 2006, 49 : 511 - 512
  • [44] Safety and efficacy of a traditional herbal medicine (Throat Coat®) in symptomatic temporary relief of pain in patients with acute pharyngitis:: A multicenter, prospective, randomized, double-blinded, placebo-controlled study
    Brinckmann, J
    Sigwart, H
    Taylor, LV
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2003, 9 (02) : 285 - 298
  • [45] Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study
    Donnenfeld, Eric D.
    Karpecki, Paul M.
    Majmudar, Parag A.
    Nichols, Kelly K.
    Raychaudhuri, Aparna
    Roy, Monica
    Semba, Charles P.
    CORNEA, 2016, 35 (06) : 741 - 748
  • [46] Efficacy and Safety of Intravenous Efgartigimod in Adults with Primary Immune Thrombocytopenia: Results of a Phase 3, Multicenter, Double-Blinded, Placebo-Controlled, Randomized Clinical Trial (ADVANCE IV)
    Broome, Catherine M.
    McDonald, Vickie
    Miyakawa, Yoshitaka
    Carpenedo, Monica
    Kuter, David J.
    Al-Samkari, Hanny
    Bussel, James B.
    Godar, Marie
    Ayguasanosa, Jaume
    De Beuf, Kristof
    Rodeghiero, Francesco
    Michel, Marc
    Newland, Adrian C.
    BLOOD, 2022, 140
  • [47] A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Samidorphan in Adults With Alcohol Dependence
    O'Malley, Stephanie
    Todtenkopf, Mark
    Ehrich, Elliot
    Silverman, Bernard L.
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S276 - S276
  • [48] A phase 2b, randomized, double-blinded, parallel-group, placebo-controlled, international, multicenter, study to evaluate the efficacy and safety of rezpegaldesleukin in adults with moderate-to-severe atopic dermatitis
    Gooderham, Melinda
    Lynde, Charles
    Alam, Maryam Shayesteh
    Sadick, Neil
    Rohan, Craig A.
    Werschler, William Philip
    Hebert, Adelaide A.
    Laquer, Vivian T.
    Sauder, Maxwell
    Del Rosso, James Q.
    Rodgers, Timothy
    Tan, Ricardo
    Schleicher, Stephen
    Murrell, Dedee F.
    Fernandez-Penas, Pablo
    Reich, Adam
    Gkalpakiotis, Spyridon
    Ruiz, Juan Ruano
    Wollenberg, Andreas
    Szepietowski, Jacek C.
    Sticherling, Michael
    Weyergraf, Ansgar J.
    Hadzavdic, Suzana Ljubojevic
    Baran, Wojciech
    Vilchez, Trinidad Montero
    Eniko, Telegdy
    Sebastian, Michael
    Chaudhry, Sohail
    Lee, Zachary
    Yu, Danni
    Liu, Yi
    Waltz, Wang
    Gilbert, Jenny
    Elko-Simms, Lucinda M.
    Fanton, Christie
    Jue, Charleen
    Tagliaferri, Mary
    Zalevsky, Jonathan
    Rosmarin, David
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 105 - 107
  • [49] Prospective, Randomized, Multicenter, Double-Blind Placebo-Controlled Study of the Safety and Efficacy of 1% D-3-Hydroxybutyrate eye drop for the Treatment of Dry Eye
    Kawakita, Tetsuya
    Takamura, Etsuko
    Shimazaki, Jun
    Ogawa, Junko
    Uchino, Miki
    Fukagawa, Kazumi
    Yoshino, Kenichi
    Tanaka, Mari
    Shimmura-Tomita, Machiko
    Tsubota, Kazuo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [50] EFFICACY AND SAFETY OF IXEKIZUMAB IN A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 3B CLINICAL TRIAL IN PATIENTS WITH MODERATE-TO-SEVERE GENITAL PSORIASIS
    Ryan, C.
    Menter, A.
    Guenther, L.
    Blauvelt, A.
    Bissonnette, R.
    Yang, F. E.
    Bleakman, Potts A.
    JOURNAL OF SEXUAL MEDICINE, 2018, 15 (02): : S6 - S7